Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness
- Autores
- Mindlin, I.; Herzog, R.; Belloli, L.; Manasova, D.; Monge Asensio, M.; Vohryzek, J.; Escrichs, A.; Alnagger, N.; Núñez, P.; Gosseries, O.; Kringelbach, M. L.; Deco, G.; Tagliazucchi, Enzo Rodolfo; Naccache, L.; Rohaut, B.; Sitt, J. D.; Sanz Perl Hernandez, Yonatan
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Disorders of consciousness (DoC) represent a challenging and complex group of neurological conditions characterised by profound disturbances in consciousness. The current range of treatments for DoC is limited. This has sparked growing interest in developing new treatments, including the use of psychedelic drugs. Nevertheless, clinical investigations and the mechanisms behind them are methodologically and ethically constrained. To tackle these limitations, we combined biologically plausible whole-brain models with deep learning techniques to characterise the low-dimensional space of DoC patients. We investigated the effects of model pharmacological interventions by including the whole-brain dynamical consequences of the enhanced neuromodulatory level of different neurotransmitters, and providing geometrical interpretation in the low-dimensional space. Our findings show that serotonergic and opioid receptors effectively shifted the DoC models towards a dynamical behaviour associated with a healthier state, and that these improvements correlated with the mean density of the activated receptors throughout the brain. These findings mark an important step towards the development of treatments not only for DoC but also for a broader spectrum of brain diseases. Our method offers a promising avenue for exploring the therapeutic potential of pharmacological interventions within the ethical and methodological confines of clinical research.
Fil: Mindlin, I.. Paris Brain Institute; Francia
Fil: Herzog, R.. Sorbonne University; Francia
Fil: Belloli, L.. Sorbonne University; Francia
Fil: Manasova, D.. Sorbonne University; Francia
Fil: Monge Asensio, M.. Universitat Pompeu Fabra; España
Fil: Vohryzek, J.. Universitat Pompeu Fabra; España
Fil: Escrichs, A.. Universitat Pompeu Fabra; España
Fil: Alnagger, N.. Université de Liège; Bélgica
Fil: Núñez, P.. Université de Liège; Bélgica
Fil: Gosseries, O.. Université de Liège; Bélgica
Fil: Kringelbach, M. L.. University of Oxford; Reino Unido
Fil: Deco, G.. Universitat Pompeu Fabra; España
Fil: Tagliazucchi, Enzo Rodolfo. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Física; Argentina. Universidad Adolfo Ibañez; Chile. Universidad de San Andrés; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Naccache, L.. Paris Brain Institute; Francia
Fil: Rohaut, B.. Paris Brain Institute; Francia
Fil: Sitt, J. D.. Sorbonne University; Francia
Fil: Sanz Perl Hernandez, Yonatan. Universidad de San Andrés; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
Neuroimaging
Disorders of consciousness
whole-brain model
Pharmacology - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/251826
Ver los metadatos del registro completo
id |
CONICETDig_c290800790768ca764e70f9091f9fbe0 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/251826 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousnessMindlin, I.Herzog, R.Belloli, L.Manasova, D.Monge Asensio, M.Vohryzek, J.Escrichs, A.Alnagger, N.Núñez, P.Gosseries, O.Kringelbach, M. L.Deco, G.Tagliazucchi, Enzo RodolfoNaccache, L.Rohaut, B.Sitt, J. D.Sanz Perl Hernandez, YonatanNeuroimagingDisorders of consciousnesswhole-brain modelPharmacologyhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Disorders of consciousness (DoC) represent a challenging and complex group of neurological conditions characterised by profound disturbances in consciousness. The current range of treatments for DoC is limited. This has sparked growing interest in developing new treatments, including the use of psychedelic drugs. Nevertheless, clinical investigations and the mechanisms behind them are methodologically and ethically constrained. To tackle these limitations, we combined biologically plausible whole-brain models with deep learning techniques to characterise the low-dimensional space of DoC patients. We investigated the effects of model pharmacological interventions by including the whole-brain dynamical consequences of the enhanced neuromodulatory level of different neurotransmitters, and providing geometrical interpretation in the low-dimensional space. Our findings show that serotonergic and opioid receptors effectively shifted the DoC models towards a dynamical behaviour associated with a healthier state, and that these improvements correlated with the mean density of the activated receptors throughout the brain. These findings mark an important step towards the development of treatments not only for DoC but also for a broader spectrum of brain diseases. Our method offers a promising avenue for exploring the therapeutic potential of pharmacological interventions within the ethical and methodological confines of clinical research.Fil: Mindlin, I.. Paris Brain Institute; FranciaFil: Herzog, R.. Sorbonne University; FranciaFil: Belloli, L.. Sorbonne University; FranciaFil: Manasova, D.. Sorbonne University; FranciaFil: Monge Asensio, M.. Universitat Pompeu Fabra; EspañaFil: Vohryzek, J.. Universitat Pompeu Fabra; EspañaFil: Escrichs, A.. Universitat Pompeu Fabra; EspañaFil: Alnagger, N.. Université de Liège; BélgicaFil: Núñez, P.. Université de Liège; BélgicaFil: Gosseries, O.. Université de Liège; BélgicaFil: Kringelbach, M. L.. University of Oxford; Reino UnidoFil: Deco, G.. Universitat Pompeu Fabra; EspañaFil: Tagliazucchi, Enzo Rodolfo. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Física; Argentina. Universidad Adolfo Ibañez; Chile. Universidad de San Andrés; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Naccache, L.. Paris Brain Institute; FranciaFil: Rohaut, B.. Paris Brain Institute; FranciaFil: Sitt, J. D.. Sorbonne University; FranciaFil: Sanz Perl Hernandez, Yonatan. Universidad de San Andrés; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaSpringer2024-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/251826Mindlin, I.; Herzog, R.; Belloli, L.; Manasova, D.; Monge Asensio, M.; et al.; Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness; Springer; Communications Biology; 7; 1; 9-2024; 1-132399-3642CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/s42003-024-06852-9info:eu-repo/semantics/altIdentifier/doi/10.1038/s42003-024-06852-9info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:49:31Zoai:ri.conicet.gov.ar:11336/251826instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:49:31.269CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness |
title |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness |
spellingShingle |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness Mindlin, I. Neuroimaging Disorders of consciousness whole-brain model Pharmacology |
title_short |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness |
title_full |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness |
title_fullStr |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness |
title_full_unstemmed |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness |
title_sort |
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness |
dc.creator.none.fl_str_mv |
Mindlin, I. Herzog, R. Belloli, L. Manasova, D. Monge Asensio, M. Vohryzek, J. Escrichs, A. Alnagger, N. Núñez, P. Gosseries, O. Kringelbach, M. L. Deco, G. Tagliazucchi, Enzo Rodolfo Naccache, L. Rohaut, B. Sitt, J. D. Sanz Perl Hernandez, Yonatan |
author |
Mindlin, I. |
author_facet |
Mindlin, I. Herzog, R. Belloli, L. Manasova, D. Monge Asensio, M. Vohryzek, J. Escrichs, A. Alnagger, N. Núñez, P. Gosseries, O. Kringelbach, M. L. Deco, G. Tagliazucchi, Enzo Rodolfo Naccache, L. Rohaut, B. Sitt, J. D. Sanz Perl Hernandez, Yonatan |
author_role |
author |
author2 |
Herzog, R. Belloli, L. Manasova, D. Monge Asensio, M. Vohryzek, J. Escrichs, A. Alnagger, N. Núñez, P. Gosseries, O. Kringelbach, M. L. Deco, G. Tagliazucchi, Enzo Rodolfo Naccache, L. Rohaut, B. Sitt, J. D. Sanz Perl Hernandez, Yonatan |
author2_role |
author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Neuroimaging Disorders of consciousness whole-brain model Pharmacology |
topic |
Neuroimaging Disorders of consciousness whole-brain model Pharmacology |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Disorders of consciousness (DoC) represent a challenging and complex group of neurological conditions characterised by profound disturbances in consciousness. The current range of treatments for DoC is limited. This has sparked growing interest in developing new treatments, including the use of psychedelic drugs. Nevertheless, clinical investigations and the mechanisms behind them are methodologically and ethically constrained. To tackle these limitations, we combined biologically plausible whole-brain models with deep learning techniques to characterise the low-dimensional space of DoC patients. We investigated the effects of model pharmacological interventions by including the whole-brain dynamical consequences of the enhanced neuromodulatory level of different neurotransmitters, and providing geometrical interpretation in the low-dimensional space. Our findings show that serotonergic and opioid receptors effectively shifted the DoC models towards a dynamical behaviour associated with a healthier state, and that these improvements correlated with the mean density of the activated receptors throughout the brain. These findings mark an important step towards the development of treatments not only for DoC but also for a broader spectrum of brain diseases. Our method offers a promising avenue for exploring the therapeutic potential of pharmacological interventions within the ethical and methodological confines of clinical research. Fil: Mindlin, I.. Paris Brain Institute; Francia Fil: Herzog, R.. Sorbonne University; Francia Fil: Belloli, L.. Sorbonne University; Francia Fil: Manasova, D.. Sorbonne University; Francia Fil: Monge Asensio, M.. Universitat Pompeu Fabra; España Fil: Vohryzek, J.. Universitat Pompeu Fabra; España Fil: Escrichs, A.. Universitat Pompeu Fabra; España Fil: Alnagger, N.. Université de Liège; Bélgica Fil: Núñez, P.. Université de Liège; Bélgica Fil: Gosseries, O.. Université de Liège; Bélgica Fil: Kringelbach, M. L.. University of Oxford; Reino Unido Fil: Deco, G.. Universitat Pompeu Fabra; España Fil: Tagliazucchi, Enzo Rodolfo. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Física; Argentina. Universidad Adolfo Ibañez; Chile. Universidad de San Andrés; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Naccache, L.. Paris Brain Institute; Francia Fil: Rohaut, B.. Paris Brain Institute; Francia Fil: Sitt, J. D.. Sorbonne University; Francia Fil: Sanz Perl Hernandez, Yonatan. Universidad de San Andrés; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
Disorders of consciousness (DoC) represent a challenging and complex group of neurological conditions characterised by profound disturbances in consciousness. The current range of treatments for DoC is limited. This has sparked growing interest in developing new treatments, including the use of psychedelic drugs. Nevertheless, clinical investigations and the mechanisms behind them are methodologically and ethically constrained. To tackle these limitations, we combined biologically plausible whole-brain models with deep learning techniques to characterise the low-dimensional space of DoC patients. We investigated the effects of model pharmacological interventions by including the whole-brain dynamical consequences of the enhanced neuromodulatory level of different neurotransmitters, and providing geometrical interpretation in the low-dimensional space. Our findings show that serotonergic and opioid receptors effectively shifted the DoC models towards a dynamical behaviour associated with a healthier state, and that these improvements correlated with the mean density of the activated receptors throughout the brain. These findings mark an important step towards the development of treatments not only for DoC but also for a broader spectrum of brain diseases. Our method offers a promising avenue for exploring the therapeutic potential of pharmacological interventions within the ethical and methodological confines of clinical research. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/251826 Mindlin, I.; Herzog, R.; Belloli, L.; Manasova, D.; Monge Asensio, M.; et al.; Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness; Springer; Communications Biology; 7; 1; 9-2024; 1-13 2399-3642 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/251826 |
identifier_str_mv |
Mindlin, I.; Herzog, R.; Belloli, L.; Manasova, D.; Monge Asensio, M.; et al.; Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness; Springer; Communications Biology; 7; 1; 9-2024; 1-13 2399-3642 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/s42003-024-06852-9 info:eu-repo/semantics/altIdentifier/doi/10.1038/s42003-024-06852-9 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Springer |
publisher.none.fl_str_mv |
Springer |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268977517035520 |
score |
13.13397 |